Hepatitis B Vaccine Market (By Type: Single Antigen Hepatitis B Vaccine, Combination Vaccines; By Dose: 3-Dose Schedule, 2-Dose Schedule, Alternate Schedule; By End User: Hospitals, Clinics, Doctor Offices, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

Table Of Content:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Hepatitis B Vaccine
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Hepatitis B Vaccine Market By Type
     1.2.2.1. Global Hepatitis B Vaccine Market Revenue and Growth Rate Comparison By Type (2015-2026)
     1.2.2.2. Global Hepatitis B Vaccine Market Revenue Share By Type in 2018
     1.2.2.3. Single Antigen Hepatitis B Vaccine
     1.2.2.4. Combination Vaccines
   1.2.3. Hepatitis B Vaccine Market By Dose
     1.2.3.1. Global Hepatitis B Vaccine Market Revenue and Growth Rate Comparison By Dose (2015-2026)
     1.2.3.1.1. 3-Dose Schedule
     1.2.3.1.2. 2-Dose Schedule
     1.2.3.1.3. Alternate Schedule
   1.2.4. Hepatitis B Vaccine Market By End User
     1.2.4.1. Global Hepatitis B Vaccine Market Revenue and Growth Rate Comparison By End User (2015-2026)
     1.2.4.2. Hospitals
     1.2.4.3. Clinics
     1.2.4.4. Doctor Offices
     1.2.4.5. Others
   1.2.5. Hepatitis B Vaccine Market By Geography
     1.2.5.1. Global Hepatitis B Vaccine Market Revenue and Growth Rate Comparison By Geography (2015-2026)
     1.2.5.2. North America Hepatitis B Vaccine Market Revenue and Growth Rate (2015-2026)
     1.2.5.3. Europe Hepatitis B Vaccine Market Revenue and Growth Rate (2015-2026)
     1.2.5.4. Asia-Pacific Hepatitis B Vaccine Market Revenue and Growth Rate (2015-2026)
     1.2.5.5. Latin America Hepatitis B Vaccine Market Revenue and Growth Rate (2015-2026)
     1.2.5.6. Middle East and Africa (MEA) Hepatitis B Vaccine Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Hepatitis B Vaccine Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Hepatitis B Vaccine Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Hepatitis B Vaccine Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Hepatitis B Vaccine Major Manufacturers in 2018

CHAPTER 4. HEPATITIS B VACCINE MARKET BY TYPE
4.1. Global Hepatitis B Vaccine Revenue By Type
4.2. Single Antigen Hepatitis B Vaccine
   4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Combination Vaccines
   4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. HEPATITIS B VACCINE MARKET BY DOSE
5.1. Global Hepatitis B Vaccine Revenue By Dose
5.2. 3-Dose Schedule
   5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. 2-Dose Schedule
   5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Alternate Schedule
   5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. HEPATITIS B VACCINE MARKET BY END USER
6.1. Global Hepatitis B Vaccine Revenue By End User
6.2. Hospitals
   6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Clinics
   6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Doctor Offices
   6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others
   6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA HEPATITIS B VACCINE MARKET BY COUNTRY
7.1. North America Hepatitis B Vaccine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Hepatitis B Vaccine Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
   7.3.1. U.S. Hepatitis B Vaccine Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   7.3.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   7.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
7.4. Canada
   7.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   7.4.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   7.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE HEPATITIS B VACCINE MARKET BY COUNTRY
8.1. Europe Hepatitis B Vaccine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Hepatitis B Vaccine Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
   8.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   8.3.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   8.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
8.4. Germany
   8.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   8.4.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   8.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
8.5. France
   8.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   8.5.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   8.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
8.6. Spain
   8.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   8.6.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   8.6.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
8.7. Rest of Europe
   8.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   8.7.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   8.7.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC HEPATITIS B VACCINE MARKET BY COUNTRY
9.1. Asia-Pacific Hepatitis B Vaccine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Hepatitis B Vaccine Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
   9.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   9.3.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   9.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.4. Japan
   9.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   9.4.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   9.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.5. India
   9.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   9.5.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   9.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.6. Australia
   9.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   9.6.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   9.6.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.7. South Korea
   9.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   9.7.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   9.7.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
   9.8.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   9.8.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   9.8.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA HEPATITIS B VACCINE MARKET BY COUNTRY
10.1. Latin America Hepatitis B Vaccine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Hepatitis B Vaccine Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
   10.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   10.3.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   10.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
10.4. Mexico
   10.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   10.4.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   10.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
10.5. Rest of Latin America
   10.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   10.5.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   10.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA HEPATITIS B VACCINE MARKET BY COUNTRY
11.1. Middle East & AFRICA Hepatitis B Vaccine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East & AFRICA Hepatitis B Vaccine Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
   11.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   11.3.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   11.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
11.4. South Africa
   11.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   11.4.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   11.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
11.5. Rest of Middle East & AFRICA
   11.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   11.5.2. Market Revenue and Forecast By Dose, 2015 - 2026 ($Million)
   11.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Sanofi
   12.1.1. Company Snapshot
   12.1.2. Overview
   12.1.3. Financial Overview
   12.1.4. Type Portfolio
   12.1.5. Key Developments
   12.1.6. Strategies
12.2. Merck & Co., Inc.
   12.2.1. Company Snapshot
   12.2.2. Overview
   12.2.3. Financial Overview
   12.2.4. Type Portfolio
   12.2.5. Key Developments
   12.2.6. Strategies
12.3. GlaxoSmithKline plc.
   12.3.1. Company Snapshot
   12.3.2. Overview
   12.3.3. Financial Overview
   12.3.4. Type Portfolio
   12.3.5. Key Developments
   12.3.6. Strategies
12.4. Indian Immunologicals Limited.
   12.4.1. Company Snapshot
   12.4.2. Overview
   12.4.3. Financial Overview
   12.4.4. Type Portfolio
   12.4.5. Key Developments
   12.4.6. Strategies
12.5. LG Chem
   12.5.1. Company Snapshot
   12.5.2. Overview
   12.5.3. Financial Overview
   12.5.4. Type Portfolio
   12.5.5. Key Developments
   12.5.6. Strategies
12.6. KM Biologics
   12.6.1. Company Snapshot
   12.6.2. Overview
   12.6.3. Financial Overview
   12.6.4. Type Portfolio
   12.6.5. Key Developments
   12.6.6. Strategies
12.7. Dynavax Technologies
   12.7.1. Company Snapshot
   12.7.2. Overview
   12.7.3. Financial Overview
   12.7.4. Type Portfolio
   12.7.5. Key Developments
   12.7.6. Strategies
12.8. Janssen Pharmaceuticals
   12.8.1. Company Snapshot
   12.8.2. Overview
   12.8.3. Financial Overview
   12.8.4. Type Portfolio
   12.8.5. Key Developments
   12.8.6. Strategies
12.9. Others
   12.9.1. Company Snapshot
   12.9.2. Overview
   12.9.3. Financial Overview
   12.9.4. Type Portfolio
   12.9.5. Key Developments
   12.9.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
   13.1.1. Initial Data Search
   13.1.2. Secondary Research
   13.1.3. Primary Research
13.2. Assumptions and Scope

Cart Summary